New drug could slow down progression of Alzheimer’s
Drug maker Biogen reported today at a major Alzheimer's conference that after 18 months of treatment, patients who received the highest dose saw a 30 percent reduction in memory and daily function decline, versus those given a placebo.
How scientists are working to save corals04:03
Colorblind deputy sees color for first time01:01
FAO Schwarz making Christmas comeback01:14
Viral GoFundMe campaign for homeless veteran was a hoax, prosecutors say01:15
Growing concern over salmonella in raw turkey across the U.S.00:51
Dartmouth students claim in lawsuit professors sexually abused them01:14